Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GP681 tablets in uncomplicated acute influenza
CTR20221824Phase 3Completed
- Sponsor
- Yaoyuan Biotechnology
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of suraxavir marboxil in influenza, sponsored by Yaoyuan Biotechnology. Started Jul 2022; status: completed.
02
Drugs
suraxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20221824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221824.